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STUDY QUESTION: Are the single nucleotide polymorphisms (SNPs) rs2075230, rs6259 and rs727428 at the sex hormone-binding
globulin (SHBG) locus, which were identiﬁed by genome-wide association studies (GWASs) for testosterone levels, associated with testoster-
one levels in Japanese men?
SUMMARY ANSWER: The SNP rs2075230, but not rs6259 and rs727428, is signiﬁcantly associated with testosterone levels in Japanese men.
WHAT IS ALREADY KNOWN: Previous GWASs have revealed that rs2075230 is associated with serum testosterone levels in 3495
Chinese men and rs6259 and rs727428 are associated with serum testosterone levels in 3225 men of European ancestry.
STUDY DESIGN, SIZE, AND DURATION: This is an independent validation study of 1687 Japanese men (901 in Cohort 1 and 786 in
Cohort 2).
PARTICIPANTS/MATERIALS, SETTING AND METHOD: Cohort 1 (20.7 ± 1.7 years old, mean ± SD) and Cohort 2 (31.2 ± 4.8
years) included samples obtained from university students and partners of pregnant women, respectively. The three SNPs were genotyped
using either TaqMan probes or restriction fragment length polymorphism PCR. Blood samples were drawn from the cubital vein of the study
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participants in the morning, and total testosterone and SHBG levels were measured using a time-resolved immunoﬂuorometric assay.
Association between each SNP and testosterone levels was evaluated by meta-analysis of the two Japanese male cohorts.
MAIN RESULTS AND THE ROLE OF CHANCE: The age of the two cohorts was signiﬁcantly different (P < 0.0001). We found that
rs2075230 was signiﬁcantly associated with serum testosterone levels (βSTD = 0.15, P = 7.2 × 10
−6); however, rs6259 and rs727428 were
not (βSTD = 0.17, P = 0.071; βSTD = 0.082, P = 0.017, respectively), after adjusting for multiple testing in a combined analysis of two Japanese
male cohorts. Moreover, rs2075230, rs6259 and rs727428 were signiﬁcantly associated with high SHBG levels (βSTD = 0.22, P = 3.4 × 10
−12;
βSTD = 0.23, P = 6.5 × 10
−6 and βSTD = 0.21, P = 3.4 × 10
−10, respectively).
LARGE SCALE DATA: Not applicable.
LIMITATIONS, REASONS FOR CAUTION: This study had differences in the age and background parameters of participants compared
to those observed in previous GWASs. In addition, the average age of participants in the two cohorts in our study also differed from one
another. Therefore, the average testosterone levels, which decrease with age, between studies or the two cohorts were different.
WIDER IMPLICATIONS OF THE FINDINGS: The three SNPs have a considerable effect on SHBG levels and hence may indirectly
affect testosterone levels.
STUDY FUNDING/COMPETING INTERESTS: This study was supported partly by the Ministry of Health and Welfare of Japan
(1013201) (to T.I.), Grant-in-Aids for Scientiﬁc Research (C) (26462461) (to Y.S.) and (23510242) (to A.Ta.) from the Japan Society for the
Promotion of Science, the European Union (BMH4-CT96-0314) (to T.I.) and the Takeda Science Foundation (to A.Ta.). There are no con-
ﬂicts of interest to declare.
Key words: independent validation study / testosterone / Japanese men / single nucleotide polymorphism / sex hormone-binding globulin /
genome-wide association studies
Introduction
Testosterone, secreted by the testes, is one of the major androgens. It
contributes to the development of sexual characteristics and genitalia
and to the maturation of sperm (Kaufman and Vermeulen, 2005). In add-
ition, differing testosterone levels have been observed to affect health
adversely causing diseases, including metabolic syndromes (Kupelian
et al., 2006; Haring et al., 2009), type two diabetes (Vikan et al., 2010),
cardiovascular diseases (Vikan et al., 2009; Araujo et al., 2011) and car-
cinogenesis (Shariﬁ et al., 2005). Approximately 50–60% of the testoster-
one in circulation is bound to sex hormone-binding globulin (SHBG) and
40–50% is bound to albumin. Unbound testosterone (1–2%), which is
termed free testosterone, and albumin-bound testosterone act as bio-
logically active hormones (Kaufman and Vermeulen, 2005).
Twin studies have shown that the heritability of sex hormone
levels, including those of testosterone and SHBG, ranges from 56%
to 81% (Ring et al., 2005; Kuijper et al., 2007). However, the genetic
determinants of sex hormone levels remain largely unknown. To
date, there have been six genome-wide association studies (GWASs)
regarding sex hormone levels, including those of testosterone,
dihydrotestosterone, SHBG, dehydroepiandrosterone sulfate and
FSH. Of these, the results of one GWAS of 3495 Chinese men
indicated the association of the SHBG locus at 17p13 with testos-
terone (P = 1.1 × 10−8 for single nucleotide polymorphism (SNP)
rs2075230) and SHBG levels (P = 4.8 × 10−19 for SNP rs2075230)
(Chen et al., 2013). A GWAS of 3225 men of European descent has
shown that the SHBG locus is associated with serum testosterone
(P = 1.3 × 10−12 for SNP rs727428; P = 5.8 × 10−8 for SNP
rs72829446; P = 3.3 × 10−7 for SNP rs6259) and dihydrotestosterone
levels (P = 1.5 × 10−11 for rs727428; P = 9.5 × 10−10 for rs72829446;
P = 4.04 × 10−9 for rs6259) (Jin et al., 2012). SNPs rs72829446 and
rs6259 were found to be in strong linkage disequilibrium (LD)
(r2: 0.88) (Jin et al., 2012).
This independent validation study was conducted to assess whether
the three SNPs (rs2075230, rs6259 and rs727428) of the SHBG locus
WHATDOES THIS MEAN FOR PATIENTS?
Previous studies have indicated that there may be a hereditary factor associated with men’s testosterone levels. One particular DNA variation
has been linked with the testosterone levels of Chinese men and two others have been linked with the testosterone levels of European men.
This research was carried out on two groups of Japanese men aimed to conﬁrm the previous results. The DNA variation which was linked to testos-
terone levels in Chinese men had similar links to the testosterone levels of the men in this study. There was also a link with levels of a protein present
in the blood which carries testosterone around the body. The two other DNA variations which had been linked with testosterone of European men
were not signiﬁcant for the Japanese men. However, the researchers did ﬁnd that the levels of the protein were associated with all three variations.
This study backs up research which has found a link between men’s DNA and their testosterone levels. As levels of testosterone as well as
the protein can affect men’s fertility and their general health, this study demonstrates that particular DNA variations can play a role in this in dif-
ferent groups of men.
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were associated with testosterone levels in two Japanese male cohorts.
The three speciﬁc SNPs have been previously reported as strongly asso-
ciated with testosterone levels with minor allele frequencies >0.05 in
the HapMap-JPT population of male subjects. Pairwise r2 of the three
SNPs measured by HapMap JPT (Phase II + III data set) are as fol-
lows: 0.129 (rs2075230–rs6259); 0.415 (rs2075230–rs727428) and
0.129 (rs6259–rs727428). Therefore, these three SNPs are in incom-
plete LD and not highly correlated with each other, although pairwise
|D′| values among the three SNPs are 1.
In addition, to provide evidence for the biological association
between the SHBG locus and testosterone levels, we conducted asso-
ciation studies between the three SNPs and SHBG and calculated free
testosterone (cFT) levels. Furthermore, we investigated associations
between the three SNPs and serum total testosterone levels, assuming
covariates for SHBG levels.
Materials andMethods
This study was approved by the ethics committees of the University of
Tokushima and St. Marianna Medical University. All participants provided
written informed consent.
Samples from two japanese cohorts
Two Japanese cohorts consisting of 901 young men from the general
Japanese population (20.7 ± 1.7 years old, mean ± SD: Cohort 1) and 786
Japanese men of proven fertility (31.2 ± 4.8 years old, mean ± SD: Cohort 2)
were included in the independent validation study. The subjects in this
study have been described in previous reports (Nakahori et al., 2012;
Iwamoto et al., 2013a,b; Sato et al., 2013a,b, 2014a,b, 2015a,b,c). Brieﬂy,
Cohort 1 samples were recruited from the university students in the
urology departments of university hospitals in four Japanese cities
(Kawasaki, Kanazawa, Nagasaki and Sapporo). Cohort 2 samples were
recruited from the partners of pregnant women who attended obstetric
clinics in four Japanese cities (Sapporo, Kanazawa, Osaka and Fukuoka).
Measurement of clinical characteristics
Physical characteristics and hormone levels of the study participants have
been analyzed in a previous study (Iwamoto et al., 2013a,b). Brieﬂy, age,
body weight and height were self-reported. BMI (kg/m2) was calculated
from body weight and height. Blood was drawn from the cubital vein of
each participant usually in the morning to reduce the effect of diurnal vari-
ation in hormone levels. Serum total testosterone and SHBG levels were
determined using a time-resolved immunoﬂuorometric assay (Delﬁa,
Wallac, Turku, Finland). It has been reported that cFT calculated using
Vermeulen’s formula (Vermeulen et al., 1999) is related to measured FT in
the Japanese population (Okamura et al., 2005; Iwamoto et al., 2009).
Further, cFT calculated using Vermeulen’s formula in the Japanese popula-
tion has been used in some other reports (Yoshinaga et al. 2014; Tanabe
et al. 2015), including two reports on our cohorts (Iwamoto et al., 2013a,b).
Therefore, the values of cFT, calculated from testosterone and SHBG
levels by using Vermeulen’s formula, were used in this study. Brieﬂy, a
value of 1 × 109 mol/l for the association constant of SHBG for testoster-
one, a value of 3.6 × 104 mol/l for the association constant of albumin for
testosterone, and a ﬁxed plasma albumin concentration of 43 g/l were
used to calculate the free testosterone (Vermeulen et al., 1999).
Genotyping and LD structure
Genomic DNA was extracted from the peripheral blood samples of subjects
using a QIAamp DNA blood kit (Qiagen; Tokyo, Japan), as previously
described (Nakahori et al., 2012; Sato et al., 2013a,b, 2014a,b, 2015a,b,c).
The rs2075230 and rs6259 SNPs were genotyped using TaqMan probes
rs2075230 (C_16165982_10; Applied Biosystems; Tokyo, Japan) and rs6259
(C_11955739_10; Applied Biosystems) in the ABI 7900HT real-time PCR
system (Applied Biosystems). The rs727428 SNP was detected by restriction
fragment length polymorphism PCR using the following primer sets: 5′-
AAGTGGACCAAGACTAGGAG-3′ (forward) and 5′-GAAGCTACTCCC
TTTGAGAC-3′ (reverse). DNA from each subject was ampliﬁed using Taq
DNA polymerase (Promega, Tokyo, Japan) under the following PCR cycling
parameters: initial denaturation at 94°C for 3min; 30 cycles of 94°C for 30 s,
60°C for 30 s and 72°C for 1min; and ﬁnal extension for 3min at 72°C. The
resulting PCR products were then digested using the HinfI restriction enzyme
(New England Biolabs Japan Inc., Tokyo, Japan). The digested products were
separated by electrophoresis on a 2.5% agarose gel. The following fragment
sizes were used for allele identiﬁcation on gels: 274 bp (A-allele) and
195 + 79 bp (G-allele). Genotyping was performed once, and the call rates of
the three SNPs were 100%.
Pairwise r2 and |D′| values among SNPs were measured by HapMap-JPT
data set (Phase II+ III). The LD plots were obtained with Haploview soft-
ware version 4.2 (Broad Institute, Cambridge, MA, USA: online at https://
www.broadinstitute.org/haploview/haploview) (Barrett et al., 2005),
using the HapMap-JPT and CEU database (Phase III) as per the deﬁnition
by Gabriel et al. (2002).
Statistical analysis
Hardy–Weinberg equilibrium (HWE) was assessed in the two cohorts by
using Pearson chi-square test for genotypes. The genotype distributions
for the three SNPs were in HWE in the two cohorts (P > 0.05).
In a previous GWAS report, testosterone values were not trans-
formed (Chen et al., 2013). On the other hand, in another GWAS
report by Jin et al., the testosterone value underwent logarithmic (log)
transformation in the analysis (Jin et al., 2012). In our study, testoster-
one values were not normally distributed. Previously, Iwamoto et al.
analyzed the same samples that were used in our study using natural
log-transformed testosterone values (Iwamoto et al., 2013a,b). When
we performed the Shapiro–Wilks normality test to conﬁrm whether
natural log-transformed testosterone is normally distributed, the results
showed signiﬁcant normality in Cohort 1 (P > 0.05) and none in
Cohort 2 (P = 0.02). However, there was a reduction in the skewness
of distribution of the natural log-transformed testosterone in Cohort
2. Therefore, we decided to use the natural log-transformed testos-
terone values for analysis in the present study. For the same reason,
SHBG and cFT also were processed using natural log-transformed
variables to minimize deviation from a normal distribution. The asso-
ciations between SNPs and sex hormone values were assessed using
standardized multiple linear regressions under an additive genetic
model, with adjustments for age and BMI. In a separate analysis,
rs6259 and rs727428 were additionally adjusted for rs2075230.
The results obtained from the two cohorts were combined in a meta-
analysis, using the meta-package for the R version 3.1.2 statistical environ-
ment (The R Project for Statistical Computing: online at http://www.
R-project.org/). The extent of heterogeneity among studies was quantiﬁed
by the I2 statistic (Higgins et al., 2003) and statistically assessed by
Cochran’s Q test. If there was no heterogeneity, as determined by an I2
statistic <50% or a P value more than 0.1, a ﬁxed-effects model using the
inverse variance method was used. Otherwise, the random-effects model
using the DerSimonian–Laird method was employed.
All statistical analyses were performed using R version 3.1.2 (http://www.
R-project.org/), and statistical signiﬁcance was considered at P values <
0.0083 (0.05/6 tests [= 2 studies × 1 trait × 3 SNPs]) for the independent
validation study and at P values < 0.0042 (0.05/12 tests [= 2 studies ×
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2 traits × 3 SNPs]) for other hormone parameters, after adjusting for
multiple testing.
Results
The sex hormone concentrations in blood samples obtained from the
two Japanese cohorts are presented in the Supplementary Table S1.
In concurrence with previous reports (Iwamoto et al., 2013b; Sato
et al., 2015a), sex hormone levels signiﬁcantly differed between
Cohorts 1 and 2.
Multiple linear regression analysis under the additive genetic model
revealed that rs2075230 and rs6259 were signiﬁcantly correlated with
testosterone levels in Cohort 1 (standardized β (βSTD) = 0.18,
P = 1.3 × 10−4 in Cohort 1) and Cohort 2 (βSTD = 0.26, P = 3.8 × 10
−4
in Cohort 2), respectively; however, rs727428 did not display a correl-
ation with testosterone levels in both cohorts, after adjusting for multiple
testing (Table I). The combined analysis of the two cohorts revealed
that only rs2075230 was signiﬁcantly associated with testosterone levels
(βSTD = 0.15, P = 7.2 × 10
−6), after adjusting for multiple testing.
Next, we investigated the association of the three SNPs with SHBG
and cFT levels in the two Japanese male cohorts. We found that the
three SNPs were signiﬁcantly associated with SHBG levels in both
cohorts (rs2075230, βSTD = 0.20, P = 6.5 × 10
−6 in Cohort 1;
βSTD = 0.25, P = 1.3 × 10
−7 in Cohort 2/rs6259, βSTD = 0.20,
P = 6.4 × 10−3 in Cohort 1; βSTD = 0.25, P = 3.0 × 10
−4 in Cohort 2/
rs727428, βSTD = 0.18, P = 8.1 × 10
−5 in Cohort 1; βSTD = 0.23,
P = 9.8 × 10−7 in Cohort 2). The combined analysis of the two cohorts
also revealed that the three SNPs were signiﬁcantly linked with SHBG
levels after adjusting for multiple testing (rs2075230, βSTD = 0.22,
P = 3.4 × 10−12; rs6259, βSTD = 0.23, P = 6.5 × 10
−6; rs727428,
βSTD = 0.21, P = 3.4 × 10
−10). However, none of the three SNPs were
signiﬁcantly associated with cFT levels after being corrected for multiple
testing (Table II).
Testosterone levels strongly correlate with SHBG levels in both
cohorts (Supplementary Tables S2 and S3). Therefore, it was sug-
gested that the observed associations between these SNPs and testos-
terone levels could be affected by inter-individual differences in
circulating SHBG levels. To ascertain this, we conducted association
analysis of the three SNPs with the testosterone levels adjusted for
SHBG levels. The associations between the three SNPs and testoster-
one levels were very weak, and non-signiﬁcant (Table III).
The rs2075230, rs6259 and rs72748 SNPs associated with SHBG
levels are located near or on the SHBG gene. Therefore, we performed
conditional logistic regression analysis additionally adjusted with
rs2075230, which had the most signiﬁcant associations with SHBG levels,
to investigate whether rs6259 and rs727428 affected SHBG levels, inde-
pendently. After adjusting for the effect of rs2075230, the strength of
associations of rs6259 and rs727428 with SHBG levels was reduced;
however, the two SNPs still showed statistically signiﬁcant associations
with SHBG levels (rs6259, βSTD = 0.14, P = 8.9 × 10
−3; rs727428,
βSTD = 0.10, P = 0.014) (Supplementary Table S4).
Discussion
Recent GWASs reported that rs2075230 was signiﬁcantly associated
with testosterone and SHBG levels in 3495 Chinese men (Chen et al.,
2013), and rs6259 and rs727428 were signiﬁcantly associated with
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testosterone levels in 3225 men of European descent (Jin et al., 2012). In
this independent validation study, rs2075230 showed signiﬁcant associ-
ation with testosterone and SHBG levels in a combined analysis of two
cohorts of Japanese men. Therefore, we could successfully validate the
results of rs2075230 obtained in the previous GWAS. However, rs6259
and rs727428 were not associated with testosterone levels in our study,
after adjustment for multiple testing in Japanese men. The previous
GWAS was conducted using 3225 samples, whereas ours was con-
ducted using 1687 samples, being approximately half the sample size.
Sample sizes have a potent inﬂuence on the results of statistical analysis.
Studies with larger sample sizes could yield highly signiﬁcant associations
of low-effect SNPs. On the other hand, studies with smaller sample sizes
may not reach that level of signiﬁcance even if the effects of SNPs are
high. Since the phenotypic variances explained by rs6259 and rs727428
were low (0.5% and 0.3%, respectively) in our study, and βSTD results of
rs727428 displayed the opposite direction compared with that of previ-
ous GWASs, it is suggested that the non-signiﬁcant associations displayed
by the two SNPs for testosterone levels cannot just be explained by the
difference in sample sizes. Regarding the characteristics of subjects, the
previous GWAS recruited men (62.76 ± 6.00 years old, mean ± SD)
from the Reduction by Dutasteride of Prostate Cancer Events/REDUCE
study, which was designed to evaluate the effect of dutasteride on pros-
tate cancer risk (Andriole et al., 2004, 2010). On the other hand, our
independent validation study recruited men from the general population
(20.7 ± 1.7 years old, mean± SD) and from a population of proven fertil-
ity (31.2 ± 4.8 years old, mean ± SD), who were generally healthy.
Testosterone levels in men peak in the second decade of life and
decrease later with age (Iwamoto et al., 2009). In fact, in our study, the
testosterone levels were observed to be lower in Cohort 2 than in
Cohort 1 patients (Supplementary Table S1), and testosterone levels of
previous GWAS subjects were observed to be lower than those
observed for our subjects. Although there is no association between tes-
tosterone levels and prostate cancer (Endogenous Hormones and
Prostate Cancer Collaborative Group et al., 2008; Sawada et al., 2010),
the difference in the average age of subjects may be one of the reasons
for the lack of association of rs6259 or rs727428 with testosterone
values. Additionally, the differences in genetic background based on eth-
nicity may also be another reason for this lack of association, since the
LD structure around these SNPs in HapMap JPT was slightly different
from that in HapMap CEU (Supplementary Fig. S1).
On the other hand, we found that rs6259 and rs727428 were signiﬁ-
cantly associated with SHBG levels in two Japanese male cohorts, who
were relatively young. It has been previously reported that the variant
allele of rs6259 is signiﬁcantly associated with higher levels of circulating
SHBG in post-menopausal women (Cousin et al., 2004; Dunning et al.,
2004; Haiman et al., 2005; Thompson et al., 2008). In addition, Ding
et al. (2009), using the Women’s Health Study cohort (60.3 ± 6.1 years
old, mean ± SD) and Physicians’ Health Study II cohort of men
(63.7 ± 7.6 years old, mean ± SD), have reported that carriers of an
rs6259 variant allele had signiﬁcantly higher SHBG levels, suggesting that
the variant allele of rs6259 may be associated with higher SHBG levels in
spite of the difference in sex, age and population. The rs727428 SNP has
also been previously reported to be associated with SHBG levels
(Thompson et al., 2008; Wickham et al., 2011; Prescott et al., 2012).
However, there are no reports, except for a previous GWAS (Chen
et al., 2013), that rs2075230 is associated with SHBG levels. Our study is
the ﬁrst to replicate the association between rs2075230 and SHBG
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5Gene polymorphisms and testosterone levels
levels. In this study, we also reported that after adjusting for SHBG levels,
the associations between the three SNPs and testosterone levels were
extremely reduced. In addition, there were no associations between the
three SNPs and cFT. Therefore, we suggested that the three SNPs have
a considerable effect on SHBG levels rather than on testosterone levels.
The values of pairwise r2 among the three SNPs (rs2075230, rs6259
and rs727428) are modest (maximum r2 = 0.415, between rs2075230
and rs727428); however, |D′| values are 1, and these SNPs are located
in the same LD block according to HapMap-JPT data (Supplementary
Fig. S1). Therefore, the three SNPs are considered to be in LD. In fact,
the signiﬁcant associations between rs6259 or rs727428 with SHBG
and testosterone were attenuated by adjustment for the effect of
rs2075230. Hence, it is suggested that the haplotype (AAG) consisting
of the effector alleles of rs2075230, rs6259 and rs727428 is possibly
associated with higher SHBG levels. The rs6259 is a non-synonymous
SNP in Exon 8 of SHBG, which leads to the substitution of asparagine
with aspartic acid in codon 356 (D356N, also known as D327N) (Cui
et al., 2005). The rs727428 is located in the downstream region of
SHBG, whereas rs2075230 is located in the upstream region of SHBG.
In general, non-synonymous SNPs in genes could exert effects on the
functions of proteins rather than on gene expression, and SNPs
located in the upstream regions of genes may inﬂuence gene expres-
sion. In this study, rs2075230 SNP located in the upstream region of
SHBG displayed a signiﬁcant association with SHBG levels. We identi-
ﬁed the most signiﬁcant SNP rs2075230 in an SP1 transcription factor
binding site using a GENETYX software program version 12 (Genetyx
Co., Tokyo, Japan). Therefore, it is suggested that the variant allele of
rs2075230 may inﬂuence the SHBG levels. To assess if more than one
haplotype within the SHBG locus have independent effects on circulat-
ing SHBG levels, ﬁne-scale genetic mapping of this locus and functional
analyses is necessary.
In summary, we could replicate the association of rs2075230 with
testosterone levels, but not the associations of rs6259 or rs727428
with testosterone levels. However, we found that the three SNPs
(rs2075230, rs6259 and rs727428) in the SHBG locus were signiﬁcantly
associated with SHBG levels.
Supplementary data
Supplementary data are available at Human Reproduction Open online.
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Supplementary Table SI Serum sex hormone levels measured in the two Japanese male cohorts.
Cohort 1 (N= 901) Cohort 2 (N= 786) P
Age (years) 20.7 ± 1.7 31.2 ± 4.8 <0.0001
BMI (kg/m2) 21.5 ± 2.5 23.3 ± 3.0 <0.0001
Testosterone (nmol/l) 23.2 ± 7.7 19.5 ± 6.6 <0.0001
SHBG (nmol/l) 26.6 ± 10.4 33.3 ± 14.6 <0.0001
cFT (pmol/l) 585.3 ± 192.7 423.3 ± 146.5 <0.0001
Data are presented as mean ± SD. P values were obtained with Student’s unpaired t-test.
SHBG, sex hormone-binding globulin; cFT, calculated free testosterone.
........................................................................................
Supplementary Table SII Correlation between age,
BMI and sex hormone parameters in Cohort 1 of
Japanese men.
Age BMI Testosterone SHBG cFT
Age 1.000
BMI 0.074* 1.000
Testosterone −0.019 −0.131*** 1.000
SHBG −0.001 −0.251*** 0.525*** 1.000
cFT −0.024 −0.017 0.871*** 0.054 1.000
Pearson’s correlation coefﬁcient is shown. *P < 0.05, **P < 0.01, ***P < 0.001.
.............................................................................................................................................................................................
Supplementary Table SIII Correlation between age, BMI and sex hormone parameters in Cohort 2 of Japanese men.
Age BMI Testosterone SHBG cFT
Age 1.000
BMI 0.172*** 1.000
Testosterone −0.197*** −0.291*** 1.000
SHBG 0.022 −0.337** 0.573*** 1.000
cFT −0.246*** −0.090* 0.780*** −0.040 1.000
Pearson’s correlation coefﬁcient is shown. *P < 0.05, **P < 0.01, ***P < 0.001.
............................... ..................................... ............................................................. ......................
.............................................................................................................................................................................................
Supplementary Table SIV An association analysis of two SNPs with serum testosterone and SHBG levels, after
adjusting for rs2075230 in two Japanese male cohorts.
SNP Cohort 1 (N = 901) Cohort 2 (N = 786) Combined Heterogeneity
βSTD (SE) P βSTD (SE) P βSTD (SE) [model]
a Pmeta Var (%)
b Phetero I
2 (%)
Testosterone
rs6259 −0.0058 (0.077) 0.94 0.22 (0.075) 3.3 × 10−3 0.11 (0.11) [R] 0.34 0.2 0.035 77.6
rs727428 −0.00058 (0.060) 0.99 −0.047 (0.064) 0.46 −0.023 (0.044) [F] 0.61 0.02 0.60 0.0
SHBG
rs6259 0.12 (0.074) 0.12 0.15 (0.073) 0.035 0.14 (0.052) [F] 8.9 × 10−3 0.4 0.72 0.0
rs727428 0.086 (0.058) 0.14 0.12 (0.061) 0.047 0.10 (0.042) [F] 0.014 0.5 0.67 0.0
Data are shown as the estimated standardized liner regression statistic βSTD, SE and P value with adjustments for age, BMI and rs2075230. Testosterone and SHBG were processed
using natural log-transformed variables. Bold numbers indicate signiﬁcance (P value < 0.05).
aThe β-coefﬁcient and its SE were summarized using an inverse variance-weighted meta-analysis, under ﬁxed-effects model [F] or the DerSimonian and Laird method under random-
effects model [R].
bPercentage of phenotypic variance explained by SNP.
JPT
CEU
Supplementary Figure S1 Linkage disequilibrium (LD) plot around the human sex hormone-binding globulin (SHBG) gene including the single
nucleotide polymorphisms (SNPs) rs2075230, rs6259 and rs727428 according to HapMap Phase III JPT (upper) and CEU (lower) data.
